102 related articles for article (PubMed ID: 22341562)
1. Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells.
Chiron D; Maïga S; Descamps G; Moreau P; Le Gouill S; Marionneau S; Ouiller T; Moreaux J; Klein B; Bataille R; Amiot M; Pellat-Deceunynck C
Blood Cells Mol Dis; 2012 Apr; 48(4):247-53. PubMed ID: 22341562
[TBL] [Abstract][Full Text] [Related]
2. Dll1/Notch activation accelerates multiple myeloma disease development by promoting CD138+ MM-cell proliferation.
Xu D; Hu J; Xu S; De Bruyne E; Menu E; Van Camp B; Vanderkerken K; Van Valckenborgh E
Leukemia; 2012 Jun; 26(6):1402-5. PubMed ID: 22094583
[No Abstract] [Full Text] [Related]
3. The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma.
Platonova N; Lazzari E; Colombo M; Falleni M; Tosi D; Giannandrea D; Citro V; Casati L; Ronchetti D; Bolli N; Neri A; Torricelli F; Crews LA; Jamieson CHM; Chiaramonte R
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834003
[TBL] [Abstract][Full Text] [Related]
4. Distinct biological roles for the notch ligands Jagged-1 and Jagged-2.
Choi K; Ahn YH; Gibbons DL; Tran HT; Creighton CJ; Girard L; Minna JD; Qin FX; Kurie JM
J Biol Chem; 2009 Jun; 284(26):17766-74. PubMed ID: 19398556
[TBL] [Abstract][Full Text] [Related]
5. A role for Jag2 in promoting uveal melanoma dissemination and growth.
Asnaghi L; Handa JT; Merbs SL; Harbour JW; Eberhart CG
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):295-306. PubMed ID: 23211831
[TBL] [Abstract][Full Text] [Related]
6. Dll3 is expressed in developing hair cells in the mammalian cochlea.
Hartman BH; Hayashi T; Nelson BR; Bermingham-McDonogh O; Reh TA
Dev Dyn; 2007 Oct; 236(10):2875-83. PubMed ID: 17823936
[TBL] [Abstract][Full Text] [Related]
7. Disrupting Jagged1-Notch signaling impairs spatial memory formation in adult mice.
Sargin D; Botly LC; Higgs G; Marsolais A; Frankland PW; Egan SE; Josselyn SA
Neurobiol Learn Mem; 2013 Jul; 103():39-49. PubMed ID: 23567106
[TBL] [Abstract][Full Text] [Related]
8. Induction of notch signaling by immobilization of jagged-1 on self-assembled monolayers.
Gonçalves RM; Martins MC; Almeida-Porada G; Barbosa MA
Biomaterials; 2009 Dec; 30(36):6879-87. PubMed ID: 19783294
[TBL] [Abstract][Full Text] [Related]
9. JAG2 induction in hypoxic tumor cells alters Notch signaling and enhances endothelial cell tube formation.
Pietras A; von Stedingk K; Lindgren D; Påhlman S; Axelson H
Mol Cancer Res; 2011 May; 9(5):626-36. PubMed ID: 21402725
[TBL] [Abstract][Full Text] [Related]
10. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitory effect of pumpkin protein on expression of Notch signal in RPMI8226 myeloma cells].
Liu TB; Yang P; Xie JM; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):1012-5. PubMed ID: 25130819
[TBL] [Abstract][Full Text] [Related]
12. NOTCH decoys that selectively block DLL/NOTCH or JAG/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth.
Kangsamaksin T; Murtomaki A; Kofler NM; Cuervo H; Chaudhri RA; Tattersall IW; Rosenstiel PE; Shawber CJ; Kitajewski J
Cancer Discov; 2015 Feb; 5(2):182-97. PubMed ID: 25387766
[TBL] [Abstract][Full Text] [Related]
13. Skeletrophin, a novel ubiquitin ligase to the intracellular region of Jagged-2, is aberrantly expressed in multiple myeloma.
Takeuchi T; Adachi Y; Ohtsuki Y
Am J Pathol; 2005 Jun; 166(6):1817-26. PubMed ID: 15920166
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines.
Houde C; Li Y; Song L; Barton K; Zhang Q; Godwin J; Nand S; Toor A; Alkan S; Smadja NV; Avet-Loiseau H; Lima CS; Miele L; Coignet LJ
Blood; 2004 Dec; 104(12):3697-704. PubMed ID: 15292061
[TBL] [Abstract][Full Text] [Related]
15. Loss of the SMRT/NCoR2 corepressor correlates with JAG2 overexpression in multiple myeloma.
Ghoshal P; Nganga AJ; Moran-Giuati J; Szafranek A; Johnson TR; Bigelow AJ; Houde CM; Avet-Loiseau H; Smiraglia DJ; Ersing N; Chanan-Khan AA; Coignet LJ
Cancer Res; 2009 May; 69(10):4380-7. PubMed ID: 19417136
[TBL] [Abstract][Full Text] [Related]
16. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
[TBL] [Abstract][Full Text] [Related]
17. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
[TBL] [Abstract][Full Text] [Related]
18. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of splenic CD8- dendritic cells and marginal zone B cells by Notch ligands.
Sekine C; Moriyama Y; Koyanagi A; Koyama N; Ogata H; Okumura K; Yagita H
Int Immunol; 2009 Mar; 21(3):295-301. PubMed ID: 19181931
[TBL] [Abstract][Full Text] [Related]
20. Activation of Notch signaling in human tongue carcinoma.
Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
